Showing results 30 to 49 of 62
< previous
next >
| Issue Date | Title | Author(s) |
| 2016-03-01 | Locating care at the end of life: Burden, vulnerability, and the practical accomplishment of dying | Macartney, JI; Broom, A; Kirby, E; Good, P; Wootton, J; Adams, J |
| 2019-03-04 | Managing diabetes at the end of life–a retrospective chart audit of two health providers in Queensland, Australia | Alqabandi, N; Haywood, A; Kindl, K; Khan, S; Good, P; Hardy, J |
| 2014-01-01 | Medical specialists' motivations for referral to specialist palliative care: A qualitative study | Kirby, E; Broom, A; Good, P; Wootton, J; Adams, J |
| 2023-06 | Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials. | Gurgenci, T; Hardy, J; Olson, R; Huggett, G; Foster, K; Good, P |
| 2019-09-12 | Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial. | Hardy, JR; Skerman, H; Philip, J; Good, P; Currow, DC; Mitchell, G; Yates, P |
| 2016-11-01 | Moral ambivalence and informal care for the dying | Broom, A; Kirby, E; Kenny, K; MacArtney, J; Good, P |
| 2016-11 | Nursing futility, managing medicine: Nurses' perspectives on the transition from life-prolonging to palliative care. | Broom, A; Kirby, E; Good, P; Lwin, Z |
| 2015-01-01 | On resilience and acceptance in the transition to palliative care at the end of life | MacArtney, JI; Broom, A; Kirby, E; Good, P; Wootton, J; Yates, PM; Adams, J |
| 2019-12-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) | Good, P; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Hardy, J |
| 2020-07-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). | Hardy, J; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Good, P |
| 2018-03-07 | Oral water soluble contrast for malignant bowel obstruction. | Syrmis, W; Richard, R; Jenkins-Marsh, S; Chia, SC; Good, P |
| 2022-09-13 | Pain management in advanced cancer: physical activity as an outcome - accelerometer feasibility study. | Lord, S; Good, P; Mielke, GI |
| 2019-07-01 | Palliative care in cirrhosis with decompensation | Plunkett, A; Mortimore, M; Good, P |
| 2019-01-02 | The pattern and timing of changes in preferred place of death for patients admitted to a community specialist palliative care service | Win, MM; Fischer, A; Good, P |
| 2023-03-01 | Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). | Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P |
| 2021-03 | Practice review: Evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer. | Hardy, J; Haywood, A; Rickett, K; Sallnow, L; Good, P |
| 2020 | Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care-A Cause for Concern? | Hardy, JR; Bundock, D; Cross, J; Gibbons, K; Pinkerton, R; Kindl, K; Good, P; Philip, J |
| 2019-12-01 | Quality use of medicines: Oral corticosteroids in advanced cancer | Pinkerton, E; Good, P; Kindl, K; Richard, R; Fischer, A; Hardy, JR |
| 2016 | Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection. | George, R; Lobb, M; Haywood, A; Khan, S; Hardy, J; Good, P; Hennig, S; Norris, R |
| 2017-01 | Rates and Predictors of Professional Interpreting Provision for Patients With Limited English Proficiency in the Emergency Department and Inpatient Ward. | Ryan, J; Abbato, S; Greer, R; Vayne-Bossert, P; Good, P |
